skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 61,673  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: Database: Taylor & Francis (Open access) remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Contraceptive risk: the FDA, Depo-Provera, and the politics of experimental medicine: by William Green, New York, NY: New York University Press, 2017, 336 pp., ISBN 9781479836987
Material Type:
Article
Add to My Research

Contraceptive risk: the FDA, Depo-Provera, and the politics of experimental medicine: by William Green, New York, NY: New York University Press, 2017, 336 pp., ISBN 9781479836987

New genetics and society, 2019-10, Vol.38 (4), p.455-457 [Peer Reviewed Journal]

ISSN: 1463-6778 ;EISSN: 1469-9915 ;DOI: 10.1080/14636778.2019.1601010

Digital Resources/Online E-Resources

2
The Current Status of Gene Therapy for the Treatment of Cancer
Material Type:
Article
Add to My Research

The Current Status of Gene Therapy for the Treatment of Cancer

Biologics, 2021-01, Vol.15, p.67-77 [Peer Reviewed Journal]

2021 Belete. ;COPYRIGHT 2021 Dove Medical Press Limited ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Belete. 2021 Belete. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S302095 ;PMID: 33776419

Full text available

3
Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee
Material Type:
Article
Add to My Research

Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Amyloid, 2018-10, Vol.25 (4), p.215-219 [Peer Reviewed Journal]

2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2019 ;ISSN: 1350-6129 ;ISSN: 1744-2818 ;EISSN: 1744-2818 ;DOI: 10.1080/13506129.2018.1549825

Digital Resources/Online E-Resources

4
Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management
Material Type:
Article
Add to My Research

Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management

Current medical research and opinion, 2019-11, Vol.35 (11), p.2015-2024 [Peer Reviewed Journal]

2019 Boehringer Ingelheim. Published by Informa UK Limited, trading as Taylor & Francis Group. 2019 ;ISSN: 0300-7995 ;EISSN: 1473-4877 ;DOI: 10.1080/03007995.2019.1647040

Digital Resources/Online E-Resources

5
Antibodies to watch in 2019
Material Type:
Article
Add to My Research

Antibodies to watch in 2019

mAbs, 2019-02, Vol.11 (2), p.219-238 [Peer Reviewed Journal]

2018 The Author(s). Published with license by Taylor & Francis Group, LLC 2018 ;2018 The Author(s). Published with license by Taylor & Francis Group, LLC 2018 The Author(s) ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2018.1556465 ;PMID: 30516432

Full text available

6
Advances with Platelet-Rich Plasma for Bone Healing
Material Type:
Article
Add to My Research

Advances with Platelet-Rich Plasma for Bone Healing

Biologics, 2024-01, Vol.18, p.29-59 [Peer Reviewed Journal]

2024 Bacevich et al. ;COPYRIGHT 2024 Dove Medical Press Limited ;2024 Bacevich et al. 2024 Bacevich et al. ;ISSN: 1177-5475 ;ISSN: 1177-5491 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S290341 ;PMID: 38299120

Full text available

7
Ultrasensitive circulating tumor DNA analysis enables precision medicine: experimental workflow considerations
Material Type:
Article
Add to My Research

Ultrasensitive circulating tumor DNA analysis enables precision medicine: experimental workflow considerations

Expert review of molecular diagnostics, 2021-03, Vol.21 (3), p.299-310 [Peer Reviewed Journal]

2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 ;ISSN: 1473-7159 ;EISSN: 1744-8352 ;DOI: 10.1080/14737159.2021.1889371

Digital Resources/Online E-Resources

8
Stem Cell Therapy for Retinal Degeneration: The Evidence to Date
Material Type:
Article
Add to My Research

Stem Cell Therapy for Retinal Degeneration: The Evidence to Date

Biologics, 2021-01, Vol.15, p.299-306 [Peer Reviewed Journal]

COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Sharma and Jaganathan. 2021 Sharma and Jaganathan. ;ISSN: 1177-5491 ;ISSN: 1177-5475 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S290331 ;PMID: 34349498

Full text available

9
Publication bias: what is it? How do we measure it? How do we avoid it?
Material Type:
Article
Add to My Research

Publication bias: what is it? How do we measure it? How do we avoid it?

Open Access Journal of Clinical Trials, 2013-01, Vol.5 (default), p.71-81 [Peer Reviewed Journal]

COPYRIGHT 2013 Dove Medical Press Limited ;COPYRIGHT 2013 Dove Medical Press Limited ;2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1179-1519 ;EISSN: 1179-1519 ;DOI: 10.2147/OAJCT.S34419

Full text available

10
Structure, heterogeneity and developability assessment of therapeutic antibodies
Material Type:
Article
Add to My Research

Structure, heterogeneity and developability assessment of therapeutic antibodies

mAbs, 2019-02, Vol.11 (2), p.239-264 [Peer Reviewed Journal]

2018 Taylor & Francis Group, LLC 2018 ;2018 Taylor & Francis Group, LLC 2018 Taylor & Francis ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2018.1553476 ;PMID: 30543482

Full text available

11
Antibodies to watch in 2023
Material Type:
Article
Add to My Research

Antibodies to watch in 2023

mAbs, 2023-12, Vol.15 (1), p.2153410-2153410 [Peer Reviewed Journal]

2022 The Author(s). Published with license by Taylor & Francis Group, LLC. 2022 ;2022 The Author(s). Published with license by Taylor & Francis Group, LLC. 2022 The Author(s) ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2022.2153410 ;PMID: 36472472

Full text available

12
Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review
Material Type:
Article
Add to My Research

Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review

Current medical research and opinion, 2022-08, Vol.38 (8), p.1391-1399 [Peer Reviewed Journal]

2022 Johnson & Johnson, LLC. Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;ISSN: 0300-7995 ;EISSN: 1473-4877 ;DOI: 10.1080/03007995.2022.2081454

Digital Resources/Online E-Resources

13
The making of bispecific antibodies
Material Type:
Article
Add to My Research

The making of bispecific antibodies

mAbs, 2017-02, Vol.9 (2), p.182-212 [Peer Reviewed Journal]

2017 The Author(s). Published with license by Taylor & Francis Group, LLC © Ulrich Brinkmann and Roland E. Kontermann 2017 ;2017 The Author(s). Published with license by Taylor & Francis Group, LLC 2017 The Author(s) ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2016.1268307 ;PMID: 28071970

Full text available

14
The "less-is-more" in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity
Material Type:
Article
Add to My Research

The "less-is-more" in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity

mAbs, 2018-07, Vol.10 (5), p.693-711 [Peer Reviewed Journal]

2018 The Author(s). Published with license by Taylor & Francis Group, LLC © Natasha A. Pereira, Kah Fai Chan, Pao Chun Lin, and Zhiwei Song 2018 ;2018 The Author(s). Published with license by Taylor & Francis Group, LLC 2018 The Author(s) ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2018.1466767 ;PMID: 29733746

Full text available

15
Antibodies to watch in 2020
Material Type:
Article
Add to My Research

Antibodies to watch in 2020

mAbs, 2020-01, Vol.12 (1), p.1703531-1703531 [Peer Reviewed Journal]

2019 The Author(s). Published with license by Taylor & Francis Group, LLC. 2019 ;2019 The Author(s). Published with license by Taylor & Francis Group, LLC. 2019 The Author(s) ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2019.1703531 ;PMID: 31847708

Full text available

16
Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee
Material Type:
Article
Add to My Research

Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Amyloid, 2020-10, Vol.27 (4), p.217-222 [Peer Reviewed Journal]

2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;ISSN: 1350-6129 ;ISSN: 1744-2818 ;EISSN: 1744-2818 ;DOI: 10.1080/13506129.2020.1835263

Digital Resources/Online E-Resources

17
Treatment Persistence of Apremilast Among Patients with Psoriatic Arthritis
Material Type:
Article
Add to My Research

Treatment Persistence of Apremilast Among Patients with Psoriatic Arthritis

Biologics, 2023-01, Vol.17, p.129-136 [Peer Reviewed Journal]

COPYRIGHT 2023 Dove Medical Press Limited ;2023 Haddad et al. 2023 Haddad et al. ;ISSN: 1177-5491 ;ISSN: 1177-5475 ;EISSN: 1177-5491 ;DOI: 10.2147/BTT.S425693

Full text available

18
Toll-like receptors and COVID-19: a two-faced story with an exciting ending
Material Type:
Article
Add to My Research

Toll-like receptors and COVID-19: a two-faced story with an exciting ending

Future science OA, 2020-09, Vol.6 (8), p.FSO605 [Peer Reviewed Journal]

2020 Carlo Buonerba ;2020 Carlo Buonerba 2020 ;ISSN: 2056-5623 ;EISSN: 2056-5623 ;DOI: 10.2144/fsoa-2020-0091 ;PMID: 32974046

Full text available

19
The therapeutic monoclonal antibody market
Material Type:
Article
Add to My Research

The therapeutic monoclonal antibody market

mAbs, 2015-01, Vol.7 (1), p.9-14 [Peer Reviewed Journal]

2015 BioProcess Technology Consultants, Inc. 2015 ;2015 BioProcess Technology Consultants, Inc. 2015 BioProcess Technology Consultants, Inc. ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.4161/19420862.2015.989042 ;PMID: 25529996

Full text available

20
Antibodies to watch in 2018
Material Type:
Article
Add to My Research

Antibodies to watch in 2018

mAbs, 2018-02, Vol.10 (2), p.183-203 [Peer Reviewed Journal]

2018 The Author(s). Published with license by Taylor & Francis Group, LLC © Hélène Kaplon and Janice M. Reichert 2018 ;2018 The Author(s). Published with license by Taylor & Francis Group, LLC 2018 The Author(s) ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2018.1415671 ;PMID: 29300693

Full text available

Results 1 - 20 of 61,673  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (60,621)

Refine My Results

Creation Date 

From To
  1. Before 1972  (22)
  2. 1972 To 1984  (80)
  3. 1985 To 1997  (195)
  4. 1998 To 2011  (5,649)
  5. After 2011  (55,728)
  6. More options open sub menu

Resource Type 

  1. Articles  (61,352)
  2. Reports  (298)
  3. Reviews  (20)
  4. magazinearticle  (3)
  5. More options open sub menu

Subject 

  1. Science & Technology  (50,202)
  2. Life Sciences & Biomedicine  (49,201)
  3. Original Research  (23,825)
  4. Medical Research  (14,272)
  5. Humans  (14,072)
  6. Medicine, Experimental  (12,408)
  7. Pharmacology & Pharmacy  (10,584)
  8. Health Aspects  (10,020)
  9. Analysis  (9,552)
  10. Animals  (9,443)
  11. Care And Treatment  (8,231)
  12. Review  (7,867)
  13. Cancer  (7,786)
  14. Patients  (6,734)
  15. Proteins  (6,480)
  16. Oncology  (5,988)
  17. Male  (5,672)
  18. Female  (5,189)
  19. Science & Technology - Other Topics  (4,746)
  20. Nanoscience & Nanotechnology  (4,584)
  21. More options open sub menu

Language 

  1. English  (61,648)
  2. Japanese  (4,255)
  3. Portuguese  (123)
  4. Norwegian  (91)
  5. Spanish  (37)
  6. French  (19)
  7. Croatian  (7)
  8. Swedish  (2)
  9. Danish  (2)
  10. German  (2)
  11. Welsh  (1)
  12. BokmÃ¥l, Norwegian  (1)
  13. Italian  (1)
  14. More options open sub menu

Searching Remote Databases, Please Wait